Sign up to access historical data
Similar companies
What is Catalyst Pharmaceuticals' current ESG score, and what does it signify?
Catalyst Pharmaceuticals' ESG score of 39 suggests a need for improvement in its sustainability and ethical practices. It falls below the industry average, indicating potential areas of concern.
Analyzing ESG, how is Catalyst Pharmaceuticals performing compared to its industry peers?
Compared to its peers, Catalyst Pharmaceuticals ranks in the 47th percentile when it comes to ESG.
Why is tracking the ESG score important for investors?
ESG scores are crucial for investors as they provide insights into a company's long-term sustainability and ethical practices. High scores can indicate lower risk and a commitment to future-proofing, which is increasingly important to socially conscious investors.
How often does AltIndex update the ESG scores for companies like Catalyst Pharmaceuticals?
AltIndex updates the ESG scores for companies, including Catalyst Pharmaceuticals, on a monthly basis. This ensures that investors have the latest data to gauge the company's ongoing commitment to environmental, social, and governance standards.
Sign up and get more insights on Catalyst Pharmaceuticals.
